Ozempic and Wegovy users are eating less, but food giant Nestlé may have figured out a way to cash in on the growing appetite for weight-loss medications. The company will launch a brand of smaller portioned, high-protein frozen foods specifically for those taking the appetite-quelling GLP-1 agonists, it announced Tuesday.
Nestlé, which produces DiGiorno pizzas and KitKats, among other frozen meal and snack brands, will roll out its Vital Pursuit line of weight-loss-drug-friendly frozen pizzas and pastas this year. The meals will retail for $4.99, a dollar more than a DiGornio personal pepperoni pizza at Target.
